Saturday, July 11, 2026
🇺🇸 FDA

Intelligence · Clinical pipeline

Phase I Pipeline Programs

First-in-human and early clinical safety studies in Phase I.

Programs 4,713
Sponsors 1,771
Drugs 4,798

Quick answer

NovaPharmaNews tracks 4,713 phase i pharmaceutical pipeline programs from ClinicalTrials.gov. First-in-human and early clinical safety studies in Phase I.

Top sponsors

Pipeline programs

Page 77 of 99

  1. SOF/VEL/VOX

    Gilead Sciences Ireland UC

    HCV Infection

    phase 1 small molecule completed

    1 trial

  2. SOLOMON-I

    Lacuna Pharma Pty Ltd

    Healthy volunteers

    phase 1 other active

    1 trial

  3. SOM 230 / Pasireotide

    United Therapeutics Europe Ltd

    Atypical Ductal Breast Hyperplasia

    phase 1 small molecule completed

    1 trial

  4. SOM230-RECAG-PK-0605

    Recordati Ireland

    Post-bariatric hypoglycaemia

    phase 1 other active

    1 trial

  5. SOM230-RECAG-PK-612

    Recordati Ireland

    Post-bariatric hypoglycaemia

    phase 1 other active

    1 trial

  6. SOR102-101

    Lacuna Pharma Pty Ltd

    Ulcerative colitis

    phase 1 other active

    1 trial

  7. SPARC1210

    Advanced Accelerator Applications

    Breast Cancer

    phase 1 small molecule terminated

    1 trial

  8. SPARC1613

    Advanced Accelerator Applications

    Recurrent or Metastatic Breast Cancer

    phase 1 small molecule completed

    1 trial

  9. SPD422

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  10. SPD489 (Lisdexamfetamine dimesylate)

    Takeda

    Schizophrenia

    phase 1 small molecule completed

    1 trial

  11. SPD503

    Takeda

    Healthy

    phase 1 small molecule completed

    2 trials

  12. SPD544

    Takeda

    ADHD

    phase 1 small molecule completed

    1 trial

  13. SPGL008

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Advanced Malignant Tumors

    phase 1 small molecule active

    1 trial

  14. SPI-62-CL-1002

    Lacuna Pharma Pty Ltd

    polymyalgia rheumatica

    phase 1 other active

    1 trial

  15. SPN-804O

    SUPERNUS PHARMACEUTICALS, INC.

    Epilepsies, Partial

    phase 1 small molecule completed

    1 trial

  16. SPN-810M

    SUPERNUS PHARMACEUTICALS, INC.

    Impulsive Aggression Comorbid With ADHD

    phase 1 small molecule completed

    1 trial

  17. SPN-817, Treatment B

    SUPERNUS PHARMACEUTICALS, INC.

    Healthy Volunteer

    phase 1 small molecule completed

    1 trial

  18. SPR206

    Spero Therapeutics

    Renal Impairment

    phase 1 small molecule completed

    1 trial

  19. SPR206

    Spero Therapeutics

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  20. SPR206

    CNS Pharmaceuticals

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  21. SPR720

    Spero Therapeutics

    Healthy Volunteer

    phase 1 small molecule completed

    1 trial

  22. SPR720

    Spero Therapeutics

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  23. SPR720 for SAD

    Spero Therapeutics

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  24. SPR741

    Spero Therapeutics

    Healthy Volunteers

    phase 1 small molecule completed

    2 trials

  25. SPR994

    Spero Therapeutics

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  26. SPVN20-CLIN-01

    Pari Pharma GmbH

    End-stage rod-cone dystrophy

    phase 1 other active

    1 trial

  27. SPY001-001

    Spyre Therapeutics

    Healthy

    phase 1 small molecule completed

    1 trial

  28. SPY002-072

    Spyre Therapeutics

    Healthy

    phase 1 small molecule active

    1 trial

  29. SPY002-091

    Spyre Therapeutics

    Healthy

    phase 1 small molecule active

    1 trial

  30. SPY003-207

    Spyre Therapeutics

    Healthy

    phase 1 small molecule active

    1 trial

  31. SP_MH20VYX

    AXIM BIOTECHNOLOGIES, INC.

    AML

    phase 1 small molecule active

    1 trial

  32. SPh/01/2024

    Sciencepharma Sp. z o.o

    Not applicable (submitted trial is a bioequivalence in healthy subjects)

    phase 1 other active

    1 trial

  33. SRF617

    Coherus Oncology

    Advanced Solid Tumor

    phase 1 small molecule completed

    1 trial

  34. SRP-1005

    Sarepta Therapeutics

    Huntington's Disease

    phase 1 small molecule active

    1 trial

  35. SRP-6004

    Sarepta Therapeutics

    Limb Girdle Muscular Dystrophy

    phase 1 gene therapy terminated

    1 trial

  36. SRP-9001-104

    Sarepta Therapeutics

    Duchenne muscular dystrophy (DMD)

    phase 1 small molecule active

    1 trial

  37. SRP-9004

    Sarepta Therapeutics

    Limb Girdle Muscular Dystrophy

    phase 1 small molecule terminated

    1 trial

  38. SSGJ-612

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Advanced Malignant Tumors

    phase 1 small molecule active

    1 trial

  39. SSGJ-613

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Arthritis, Gouty

    phase 1 small molecule active

    1 trial

  40. SSGJ-613

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Systemic Juvenile Idiopathic Arthritis

    phase 1 small molecule active

    1 trial

  41. SSGJ-705

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Receptor, ErbB-2

    phase 1 small molecule active

    1 trial

  42. SSGJ-706

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Advanced Solid Tumors Patients

    phase 1 small molecule active

    1 trial

  43. SSGJ-709

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Advanced Malignant Tumors

    phase 1 small molecule active

    1 trial

  44. SSP-002358

    Takeda

    Healthy

    phase 1 small molecule completed

    1 trial

  45. SSP-004184

    Takeda

    Hepatic Impairment

    phase 1 small molecule completed

    1 trial

  46. SSP-004184

    Takeda

    Impaired Renal Function

    phase 1 small molecule completed

    1 trial

  47. SSP-004184AQ

    Takeda

    Healthy

    phase 1 small molecule completed

    1 trial

  48. SSP-004184SS

    Takeda

    Healthy

    phase 1 small molecule completed

    1 trial

Frequently asked questions

How many Phase I pipeline programs are in the directory?

4,713 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.